FDA Device Recalls

Recalls /

#130239

Product

Dimension Vista HbA1c

FDA product code
LCPAssay, Glycosylated Hemoglobin
Device class
Class 2
Medical specialty
Hematology
510(k) numbers
K102045
Affected lot / code info
catalog #K3105A, material #10470481, All in-date lots

Why it was recalled

In March, Siemens Healthcare Diagnostics issued an Urgent Medical Device Correction for decreased recovery of patient samples with the Dimension Vista® CSA & CSAE Flex® reagent cartridges when whole blood samples are run from Small Sample Containers (SSC). Siemens has confirmed that when whole blood samples are run from SSC, HbA1c values may exhibit a percent bias ranging from - 8.2% t

Root cause (FDA determination)

Device Design

Action the firm took

An Urgent Medical Device Correction, dated August 2014, was provided to all Dimension Vista HbA1c customers who received the affected lots to notify them of the issue, the potential risk to health, and actions to be taken by customers.

Recalling firm

Firm
Siemens Healthcare Diagnostics, Inc.
Address
500 Gbc Dr PO BOX 6101, Ms 514, Newark, Delaware 19702-2466

Distribution

Distribution pattern
Worldwide Distribution: US (nationwide) and country of: Canada.

Timeline

Recall initiated
2014-08-14
Posted by FDA
2014-10-24
Terminated
2015-08-10
Status

Source: openFDA Device Recall endpoint. Recall record ID #130239. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

— recall: Dimension Vista HbA1c · FDA Device Recalls